Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1500

1.
2.
4.

Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.

Knudsen JD, Frimodt-Møller N, Espersen F.

J Antimicrob Chemother. 1998 Apr;41(4):451-9.

PMID:
9598776
6.

Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.

Knudsen JD, Odenholt I, Erlendsdottir H, Gottfredsson M, Cars O, Frimodt-Møller N, Espersen F, Kristinsson KG, Gudmundsson S.

Antimicrob Agents Chemother. 2003 Aug;47(8):2499-506.

7.
8.
10.

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.

den Hollander JG, Knudsen JD, Mouton JW, Fuursted K, Frimodt-Møller N, Verbrugh HA, Espersen F.

Antimicrob Agents Chemother. 1998 Feb;42(2):377-82.

11.

In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Moine P, Vallée E, Azoulay-Dupuis E, Bourget P, Bédos JP, Bauchet J, Pocidalo JJ.

Antimicrob Agents Chemother. 1994 Sep;38(9):1953-8.

12.

Penicillin pharmacodynamics in four experimental pneumococcal infection models.

Erlendsdottir H, Knudsen JD, Odenholt I, Cars O, Espersen F, Frimodt-Møller N, Fuursted K, Kristinsson KG, Gudmundsson S.

Antimicrob Agents Chemother. 2001 Apr;45(4):1078-85.

13.

Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Tateda K, Takashima K, Miyazaki H, Matsumoto T, Hatori T, Yamaguchi K.

Antimicrob Agents Chemother. 1996 Jun;40(6):1520-5.

14.

Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.

Chavanet P, Dalle F, Delisle P, Duong M, Pechinot A, Buisson M, D'Athis P, Portier H.

J Antimicrob Chemother. 1998 Feb;41(2):237-46.

PMID:
9533466
17.

[Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].

Gómez-Lus ML, García Y, Valero E, Amores R, Fuentes F.

Rev Esp Quimioter. 2000 Sep;13(3):306-13. Spanish.

PMID:
11086282
18.
19.

Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.

Zhanel GG, DeCorby M, Noreddin A, Mendoza C, Cumming A, Nichol K, Wierzbowski A, Hoban DJ.

J Antimicrob Chemother. 2003 Jul;52(1):83-8. Epub 2003 May 29.

PMID:
12775677
20.

MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.

Spangler SK, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 1997 Jan;41(1):148-55.

Supplemental Content

Support Center